This is a pivotal, prospective, active-controlled, randomized, double blinded (blinded evaluator and subject), intra-individual split-face comparison, non-inferiority study of DKL crosslinked sodium hyaluronate 26 versus Juvederm Volumaâ„¢ after treatment of subcutaneous to upper-periostea tissue, or deep dermis implantation for cheek augmentation and age-related facial-volume deficit.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Comparison of the rate of responders determined by the aesthetic improvement of the midface according to live on-site evaluator-rated MMVS at 6 months post-treatment between the investigational device and comparator product.
Timeframe: Baseline (pre-treatment) to 6 months post-treatment